Recent Finacing
Recent Raise
Borealis Biosciences develops targeted RNA therapeutics for kidney disease subpopulations, operating a 23k sq ft Vancouver research site with wet labs, vivarium, chemistry, translational data science and multidisciplinary discovery team.
